We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
COPT Defense Properties
CDP
$4.21B
| $471K | ﹤0.01% |
22,394
-2,720
| -11% | -$69.2K |
|
1802
Renasant Corp
RNST
$3.91B
| $470K | ﹤0.01% |
15,586
-657
| -4% | -$23K |
|
1803
Stock Yards Bancorp
SYBT
$2.6B
| $470K | ﹤0.01% |
14,343
-6,700
| -32% | -$214K |
|
1804
Euronet Worldwide
EEFT
$2.7B
| $469K | ﹤0.01% |
4,584
-619
| -12% | -$68.5K |
|
1805
Plexus
PLXS
$7.23B
| $469K | ﹤0.01% |
9,188
-19,095
| -68% | -$1.08M |
|
1806
Ball Corp
BALL
$16.8B
| $468K | ﹤0.01% |
+10,181
| New | +$476K |
|
|
IO
1807
DELISTED
ION Geophysical Corporation
IO
| $467K | ﹤0.01% |
90,233
-118,468
| -57% | -$1.2M |
|
1808
Arbutus Biopharma
ABUS
$915M
| $466K | ﹤0.01% |
121,642
+75,066
| +161% | +$370K |
|
1809
Evercore
EVR
$11.8B
| $466K | ﹤0.01% |
6,518
-653
| -9% | -$53.6K |
|
1810
Matsons
MATX
$6.18B
| $466K | ﹤0.01% |
14,557
+9,253
| +174% | +$342K |
|
1811
Voyager Therapeutics
VYGR
$201M
| $466K | ﹤0.01% |
49,589
+30,608
| +161% | +$393K |
|
1812
MGE Energy Inc
MGEE
$3.08B
| $463K | ﹤0.01% |
7,723
-14,833
| -66% | -$945K |
|
1813
Agree Realty
ADC
$9.41B
| $462K | ﹤0.01% |
7,822
-23,741
| -75% | -$1.36M |
|
1814
Federal Signal
FSS
$7.83B
| $458K | ﹤0.01% |
23,010
-3,770
| -14% | -$85.9K |
|
1815
Pembina Pipeline
PBA
$27.6B
| $457K | ﹤0.01% |
15,420
-249
| -2% | -$8.26K |
|
1816
AtriCure
ATRC
$2.11B
| $456K | ﹤0.01% |
14,894
-6,371
| -30% | -$198K |
|
|
MINI
1817
DELISTED
Mobile Mini Inc
MINI
| $453K | ﹤0.01% |
14,266
+291
| +2% | +$11.3K |
|
|
FG
1818
DELISTED
FGL Holdings Ordinary Shares
FG
| $447K | ﹤0.01% |
67,067
-5,949
| -8% | -$46.2K |
|
1819
Community Health Systems
CYH
$423M
| $445K | ﹤0.01% |
157,854
+40,519
| +35% | +$139K |
|
1820
Upland Software
UPLD
$15.4M
| $444K | ﹤0.01% |
1,634
-167
| -9% | -$50.1K |
|
|
JNCE
1821
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $443K | ﹤0.01% |
+131,443
| New | +$614K |
|
1822
Hubbell
HUBB
$27.2B
| $441K | ﹤0.01% |
4,435
+2,567
| +137% | +$282K |
|
1823
Amphastar Pharmaceuticals
AMPH
$916M
| $440K | ﹤0.01% |
22,103
-2,523
| -10% | -$49.7K |
|
|
CXO
1824
DELISTED
CONCHO RESOURCES INC.
CXO
| $439K | ﹤0.01% |
4,271
-8,290
| -66% | -$1.1M |
|
1825
Preferred Bank
PFBC
$1.25B
| $437K | ﹤0.01% |
10,071
+1,140
| +13% | +$58.2K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.